跳至主要内容
临床试验/NCT05195216
NCT05195216已完成不适用

Psychosocial Factors and Quality of Life in the Effect of Fear of COVID-19 With Cystic Fibrosis

Elif Kabasakal1 个研究点 分布在 1 个国家目标入组 128 人开始时间: 2021年11月20日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
128
试验地点
1
主要终点
fear of covid-19

研究概览

简要总结

The purpose of this study; The COVID-19 pandemic is to investigate the effects of COVID-19 fear levels of patients with cystic fibrosis on the psychosocial and quality of life levels of individuals.

详细描述

After individuals were informed about the study, it was administered to individuals who gave written informed consent.This study was carried out on individuals with cystic fibrosis and healthy individuals who meet the eligibility requirements, through online forms.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
16 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • be 16 years of age or older
  • Having been diagnosed with Cystic Fibrosis
  • Volunteering to participate in the research

排除标准

  • Being mentally incapable of successfully applying the scales to be applied for evaluation purposes
  • Being treated with sedative and antiepileptic drugs
  • Pregnancy

结局指标

主要结局

fear of covid-19

时间窗: November- December/2021

COVID-19 Fear Scale: This scale is a one-dimensional instrument consisting of seven items with robust psychometric properties that measure fear of COVID-19. It has a 5-point Likert-type rating system (1: Strongly disagree, 5: Strongly agree). It is reliable and valid in assessing fear of COVID-19 among the general population. Turkish validity and reliability of the scale were ensured.

次要结局

  • psychosocial factors(November-December/2021November-December/2021)

研究者

发起方
Elif Kabasakal
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Elif Kabasakal

ekabasakal

Medipol University

研究点 (1)

Loading locations...

相似试验